Decisive Steps From Early Access to Post-Approval
Pricing and Reimbursement is often sequenced globally, which takes time. Some patients wait years to receive medicines. Compassionate use programs are limited in scope. Charged for Named Patient Programs are sustainable, broaden access (beyond priority markets), and bring medicines to more patients.
Decisive Consulting can support you in building the Named Patient Program that meets your needs (charged, free of charge, and early through to post-approval access programs).
Plan with Access in mind:
We see Named Patient Programs as a Critical Access tool
Establishing an early access program as part of the journey to full pricing and reimbursement
Developing a sustainable (funded) program that generates the revenue to ensure longevity and robust patient access
Europe to global reach
Find the Gaps:
We help make your access program stronger.
Identifying the best 3PL to deliver your access program
Conducting robust global – local KOL mapping, ensuring you know the top experts in every country
Managing 3PL contracts and supporting identification of local provider where legally needed
Supporting compliance, legal questions
Deep dive into country funding route for your specific medicine
Virtual Team
We flex to your needs bringing an industry experienced team that can plug gaps in your organisation and deliver the Named Patient Program you need. From bespoke ad-hoc needs to a team that will run every aspect of the NPP and 3PL management for you from:
RFP writing and assessment (to ensure your needs are covered)
3PL management
Issue management
Market Assessments (including KOL mapping)
Ensuring compliant communications
Create and manage a virtual field team (KAM-MSL-MD support)
Symposium- Meeting in the box support
Negotiations – contract/ funding
Contact us.
Book an appointment to find out more and discuss how we can help you. Or fill in the contact form.